Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
SIGA Technologies is a pharmaceutical company specializing in antiviral drugs, notably TPOXX (tecovirimat), for smallpox and other orthopoxvirus infections. It supplies government and international markets, focusing on biodefense and pandemic preparedness. The company relies on third-party manufacturers, holds extensive patents, and navigates complex regulatory environments globally to develop and commercialize its antiviral therapies.
This description was generated via AI from an annual report. Updated about 1 year ago.